Affinity Asset Advisors, LLC - 22 Jan 2026 SCHEDULE 13G/A Report for Lexeo Therapeutics, Inc. Common Stock, $0.0001 par value per share (LXEO)

Filing Manager: Affinity Asset Advisors, LLC
Reporting Manager: Affinity Asset Advisors, LLC
Security: Lexeo Therapeutics, Inc. Common Stock, $0.0001 par value per share
Symbol: LXEO
Shares outstanding: 73,488,169 shares
Disclosed Ownership: 5,217,660 shares
Ownership: 7.1%
Form type: SCHEDULE 13G/A
Filing time: 29 Jan 2026, 19:58:43 UTC
Date of event: 22 Jan 2026
Previous filing: 04 Jun 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Affinity Asset Advisors, LLC	7.1%	5,217,660	5,217,660	0	/s/ Andrew Weinstein	Andrew Weinstein, Chief Financial Officer and Chief Compliance Officer
Michael Cho	7.1%	5,217,660	5,217,660	0	/s/ Michael Cho	Michael Cho, Self